Literature DB >> 27909990

Orexin/Hypocretin Signaling.

Jyrki P Kukkonen1.   

Abstract

Orexin/hypocretin peptide (orexin-A and orexin-B) signaling is believed to take place via the two G-protein-coupled receptors (GPCRs), named OX1 and OX2 orexin receptors, as described in the previous chapters. Signaling of orexin peptides has been investigated in diverse endogenously orexin receptor-expressing cells - mainly neurons but also other types of cells - and in recombinant cells expressing the receptors in a heterologous manner. Findings in the different systems are partially convergent but also indicate cellular background-specific signaling. The general picture suggests an inherently high degree of diversity in orexin receptor signaling.In the current chapter, I present orexin signaling on the cellular and molecular levels. Discussion of the connection to (potential) physiological orexin responses is only brief since these are in focus of other chapters in this book. The same goes for the post-synaptic signaling mechanisms, which are dealt with in Burdakov: Postsynaptic actions of orexin. The current chapter is organized according to the tissue type, starting from the central nervous system. Finally, receptor signaling pathways are discussed across tissues, cell types, and even species.

Entities:  

Keywords:  Adenylyl cyclase; Calcium; Diacylglycerol lipase; Endocannabinoid; Gi; Gq; Gs; Heterotrimeric G-protein; Hypocretin; K+ channel; Na+/Ca2+-exchanger; Non-selective cation channel; OX1 receptor; OX2 receptor; Orexin; Phospholipase A2; Phospholipase C; Phospholipase D; Protein kinase C

Mesh:

Substances:

Year:  2017        PMID: 27909990     DOI: 10.1007/7854_2016_49

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  11 in total

1.  The arousal effect of hyperbaric oxygen through orexin/hypocretin an upregulation on ketamine/ethanol-induced unconsciousness in male rats.

Authors:  Hetao Bian; Lei Huang; Bo Li; Qin Hu; Xiping Liang; Jiping Tang; John H Zhang
Journal:  J Neurosci Res       Date:  2019-03-21       Impact factor: 4.164

2.  Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol.

Authors:  Rachel I Anderson; David E Moorman; Howard C Becker
Journal:  Handb Exp Pharmacol       Date:  2018

3.  Orexin receptors in GtoPdb v.2021.3.

Authors:  Paul Coleman; Luis de Lecea; Anthony Gotter; Jim Hagan; Daniel Hoyer; Thomas Kilduff; Jyrki P Kukkonen; Rod Porter; John Renger; Jerome M Siegel; Gregor Sutcliffe; Neil Upton; Christopher J Winrow
Journal:  IUPHAR BPS Guide Pharm CITE       Date:  2021-09-02

Review 4.  Orexin Receptor Antagonists and Insomnia.

Authors:  Xin Wu; Tao Xue; Zhouqing Chen; Zhong Wang; Gang Chen
Journal:  Curr Psychiatry Rep       Date:  2022-08-16       Impact factor: 8.081

Review 5.  Layer- and Cell Type-Specific Modulation of Excitatory Neuronal Activity in the Neocortex.

Authors:  Gabriele Radnikow; Dirk Feldmeyer
Journal:  Front Neuroanat       Date:  2018-01-30       Impact factor: 3.856

6.  Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson's Disease.

Authors:  Mei-Fang Liu; Yan Xue; Cui Liu; Yun-Hai Liu; Hui-Ling Diao; Ying Wang; Yi-Peng Pan; Lei Chen
Journal:  Front Neurosci       Date:  2018-11-15       Impact factor: 4.677

Review 7.  Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases.

Authors:  Alain Couvineau; Thierry Voisin; Pascal Nicole; Valérie Gratio; Catalina Abad; Yossan-Var Tan
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-22       Impact factor: 5.555

Review 8.  Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions.

Authors:  Alain Couvineau; Thierry Voisin; Pascal Nicole; Valerie Gratio; Anne Blais
Journal:  World J Gastroenterol       Date:  2021-11-28       Impact factor: 5.742

9.  Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics.

Authors:  Miles D Thompson; Takeshi Sakurai; Innocenzo Rainero; Mary C Maj; Jyrki P Kukkonen
Journal:  Pharmaceuticals (Basel)       Date:  2017-10-08

Review 10.  Orexins, Sleep, and Blood Pressure.

Authors:  Mariusz Sieminski; Jacek Szypenbejl; Eemil Partinen
Journal:  Curr Hypertens Rep       Date:  2018-07-10       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.